Li T - Search Results

1

Extranodal NK/T-cell lymphoma, nasal type: a report of 73 cases at MD Anderson Cancer Center.

Li S, Feng X, Li T, Zhang S, Zuo Z, Lin P, Konoplev S, Bueso-Ramos CE, Vega F, Medeiros LJ, Yin CC. Li S, et al. Among authors: li t. Am J Surg Pathol. 2013 Jan;37(1):14-23. doi: 10.1097/PAS.0b013e31826731b5. Am J Surg Pathol. 2013. PMID: 23232851

2

Analysis of 142 Northern Chinese patients with peripheral T/NK-Cell lymphomas: subtype distribution, clinicopathologic features, and prognosis.

Ren YL, Nong L, Zhang S, Zhao J, Zhang XM, Li T. Ren YL, et al. Among authors: li t. Am J Clin Pathol. 2012 Sep;138(3):435-47. doi: 10.1309/AJCPWKJ3GPFRT7GA. Am J Clin Pathol. 2012. PMID: 22912362

3

The downregulation of PRDM1/Blimp-1 is associated with aberrant expression of miR-223 in extranodal NK/T-cell lymphoma, nasal type.

Liang L, Nong L, Zhang S, Zhao J, Ti H, Dong Y, Zhang B, Li T. Liang L, et al. Among authors: li t. J Exp Clin Cancer Res. 2014 Jan 17;33(1):7. doi: 10.1186/1756-9966-33-7. J Exp Clin Cancer Res. 2014. PMID: 24438193 Free PMC article.

4

The Clinicopathological Factors Associated with Disease Progression in Luminal A Breast Cancer and Characteristics of Metastasis: A Retrospective Study from A Single Center in China.

Ye J, Wang W, Xin L, Owen S, Xu L, Duan X, Cheng Y, Zhang H, Zhang S, Li T, Liu Y. Ye J, et al. Among authors: li t. Anticancer Res. 2017 Aug;37(8):4549-4556. doi: 10.21873/anticanres.11852. Anticancer Res. 2017. PMID: 28739751 Free article.

5

[Analysis on clinical and pathological characteristics of 66 patients with stage IV breast cancer].

Gao G, Zhang H, Zhang S, Liu Q, Xu L, Ye J, Duan X, Li T, Liu Y. Gao G, et al. Among authors: li t. Zhonghua Wai Ke Za Zhi. 2015 Dec 1;53(12):935-40. Zhonghua Wai Ke Za Zhi. 2015. PMID: 26850666 Chinese.

6

Primary sclerosing epithelioid fibrosarcoma of chest wall in a patient with breast cancer: a case report.

Zhang S, Zhang Y, Guo L, Zhang H, Yu Y, Li D, Xu L, Duan X, Liu Y, Li T. Zhang S, et al. Among authors: li d, li t. Int J Clin Exp Pathol. 2019 Jan 1;12(1):365-371. eCollection 2019. Int J Clin Exp Pathol. 2019. PMID: 31933753 Free PMC article.

7

Intratumoral heterogeneity of HER2 gene amplification in occult breast cancer.

Xin L, Zhang H, Zhang S, Ye J, Li T, Liu Y. Xin L, et al. Among authors: li t. Chin Med J (Engl). 2014;127(20):3676-7. Chin Med J (Engl). 2014. PMID: 25316250 No abstract available.

8

[Evaluation and indication of human epithelial growth factor receptor 2 status in breast carcinoma with amplified chromosome].

Zhang S, Wang Y, Guo ZM, Zhang H, Xu L, Liu YH, Li T. Zhang S, et al. Among authors: li t. Beijing Da Xue Xue Bao Yi Xue Ban. 2014 Oct 18;46(5):686-90. Beijing Da Xue Xue Bao Yi Xue Ban. 2014. PMID: 25331387 Free article. Chinese.

9

[Predictive factors of pathological complete response in primary human epidermal growth factor receptor 2-positive breast cancer treated with trastuzumab-based neoadjuvant chemotherapy].

Liu S, Xu L, Zhang H, Zhang S, Li T, Duan X, Liu Y. Liu S, et al. Among authors: li t. Zhonghua Wai Ke Za Zhi. 2016 Feb 1;54(2):94-8. doi: 10.3760/cma.j.issn.0529-5815.2016.02.004. Zhonghua Wai Ke Za Zhi. 2016. PMID: 26876074 Chinese.

10

Clinicopathologic analysis of 722 breast cancer patients who met the inclusion criteria of the TAILORx trial.

Xiang HY, Liu YH, Zhang H, Zhang S, Xin L, Xu L, Ye JM, Li T, Duan XN, Liu Q. Xiang HY, et al. Among authors: li t. Chin Med J (Engl). 2019 Dec 20;132(24):2914-2919. doi: 10.1097/CM9.0000000000000548. Chin Med J (Engl). 2019. PMID: 31809316 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39,529 results

Search Page

Filters